Skip to main content
. Author manuscript; available in PMC: 2013 Jul 25.
Published in final edited form as: Pediatr Blood Cancer. 2010 Apr;54(4):552–558. doi: 10.1002/pbc.22327

TABLE IV.

Multivariate Analysis of HLA Alloimmunization in SCD

Variable Odds ratio Wald 95% CI P-value
RBC antibodies 3.61 (1.05–12.3) 0.041
Age ≥13 3.08 (0.69–13.8) 0.14
Lifetime number of RBC unitsa
 25–49 0.85 (0.05–15.5) 0.91
 50–99 8.13 (0.92–72.2) 0.06
 ≥100 2.78 (0.20–38.0) 0.44
Chronic transfusion therapyb
 Current 0.52 (0.04–6.91) 0.62
 Past 0.35 (0.03–3.97) 0.39
LR historyc
 Not exclusively LR 0.81 (0.15–4.40) 0.81
 Incomplete LR history 1.78 (0.28–11.4) 0.54
Days since last RBC transfusion 1.00 (0.999–1.002) 0.63
Splenectomy 0.25 (0.04–1.57) 0.14

LR, leukoreduction. Odds ratios (95% confidence intervals) for each predictor variable are shown.

a

Reference group: <25 units;

b

Reference group: never received chronic transfusion therapy;

c

Reference group: exclusively LR units.